Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
ACN Newswire能提供全方位的服務。對於希望向媒體、業界和金融市場披露和傳播資訊的公司和組織,我們能為您安排即時的新聞發佈。ACN Newswire的新聞稿包括英文、簡體中文、繁體中文、韓文和日文等多種語言版本。
Tuesday, 12 September 2023, 21:22 HKT/SGT
Share:

來源 Ad Scientiam
Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot

PARIS, FRANCE, 2023年9月12日 - (亞太商訊)  - Ad Scientiam, a global leader in digital biomarkers, has announced a partnership with Sanofi to launch MS-DETECT, an international, multicenter, longitudinal study. MS-DETECT aims to evaluate the ability of MSCopilot(R), a medical software device, to detect early signs of disability worsening in people with multiple sclerosis (PwMS). The study will draw upon Ad Scientiam's expertise in MS and is financially supported by Sanofi.

Multiple Sclerosis (MS) is a chronic immune-mediated disease of the central nervous system that affects 2.8 million people worldwide. The disease is characterized by early inflammatory demyelination and subsequent neurodegeneration. Current clinical evaluation of PwMS relies mainly on the Expanded Disability Status Scale (EDSS), which has several limitations. To improve on these assessments, Ad Scientiam has developed MSCopilot(R), a software medical device that addresses four dimensions: ambulation/mobility, upper extremity function, cognition, and low-contrast visual acuity.

MS-DETECT's main objective is to determine MSCopilot(R)'s ability to identify subtle and early disability worsening. This will be performed by evaluating MSCopilot(R) individual and/or composite scores as compared to the Multiple Sclerosis Functional Composite (MSFC) and the EDSS.

"MS-DETECT is a pioneering large-scale longitudinal study that explores digital biomarkers for the early detection of disease progression. This study will provide important data to both clinicians and people living with MS," according to Dr. Saad Zinai, Chief Medical Officer at Ad Scientiam.

"Disability worsening in MS has been recently redefined and we now know that this progression can occur independently of relapses. With MS-DETECT, we have an opportunity to develop a digital solution to help detect and monitor the effects of smoldering disease, and evolve treatment goals for MS patients," explains Su-Peing Ng, Global Head of Medical Affairs - Specialty Care at Sanofi.

The study also aims to assess the MSCopilot(R) performance, safety, usability and satisfaction with the solution.

"Disease progression can be hard to detect in routine practice. I believe these novel digital biomarkers are key to help clinicians make appropriate treatment decisions and, ultimately, improve patients' care," said Prof. Patrick Vermersch (Lille, France), Coordinating Investigator and Chairman of the Study Steering Committee.

The MS-DETECT study will include 314 PwMS and will be conducted in the United States, Canada, Germany, Italy, Spain, Denmark and France. Several investigative sites have already been initiated in North America and Europe and first patients are expected to participate in the study during Q3 2023.
Check our LinkedIn, Facebook, Instagram pages or visit adscientiam.com

Contact Information
Saad Zinai
Chief Medical Officer
szinai@adscientiam.com
+33768008666

Matthieu Lamy
President
mlamy@adscientiam.com
+33768008666

話題 Press release summary


http://www.acnnewswire.com
From the Asia Corporate News Network

Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network


Latest Press Releases
Legend Holdings 2025 Annual Results: Both Revenue and Net Profit Rise  
Apr 1, 2026, 10:17 HKT/SGT
Thunderstruck Resources Announces Strategic Investment by Zhaojin International Gold Co. Ltd.  
Apr 1, 2026, 06:00 HKT/SGT
A Closer Look at Fosun International 2025 Annual Results: 'One-Off Risk Clearance' Paves Way for 'RMB10 Billion Profit'  
Mar 31, 2026, 23:06 HKT/SGT
Toyota Motor Corporation aims to join Daimler Truck and Volvo Group as equal shareholder in the fuel cell joint venture cellcentric  
Tuesday, March 31, 2026 10:39:00 PM
GOME Retail Delivers Marked Improvement in 2025 Results  
Mar 31, 2026, 21:36 HKT/SGT
Datavault AI and Coppercore Inc. Announce Tokenization of High-Grade Copper Resources into Coppercoin(TM)  
Mar 31, 2026, 21:15 HKT/SGT
Honda Announces the Establishment of PathAhead Co., Ltd., a Startup Originated from IGNITION, a Honda New Business Creation Program  
Tuesday, March 31, 2026 8:58:00 PM
TANAKA Memorial Foundation Announces Recipients of Precious Metals Research Grants  
Mar 31, 2026, 20:00 HKT/SGT
Hitachi Digital Services Strengthens OT-IT Integration with Manufacturing Operations Management Platform  
Tuesday, March 31, 2026 6:14:00 PM
Hong Kong exporter sentiment moderates amid global uncertainties  
Mar 31, 2026, 17:30 HKT/SGT
More Press release >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
頂部 | 關於我們 | 服務 | 合作夥伴 | 聯繫 | 隱私權政策 | 使用條款 | RSS
美國: +1 214 890 4418 | 中國: +86 181 2376 3721 | 香港: +852 8192 4922 | 新加坡: +65 6549 7068 | 東京: +81 3 6859 8575